Potential biomarkers for the early detection of acute kidney injury after percutaneous nephrolithotripsy

References

• Türk KT, Petrik A, Sarica K, et al. Guidelines on urolithiasis. European Association of Urology; 2010
   Google Scholar
• Jiang C, Qi C, Sun K, Xia L, Xue W, Huang Y. Diagnostic value of N-acetyl-β-D-glucosaminidase for the early prediction of acute kidney injury after percutaneous nephrolithotripsy. Exp Ther Med. 2013;5(1):197–200
   PubMed Web of Science ®Google Scholar
• Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: A cohort analysis. Crit Care. 2006;10(3):R73
   PubMed Web of Science ®Google Scholar
• Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006;34(7):1913–1917
   PubMed Web of Science ®Google Scholar
• Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury following cardiac surgery. Lancet 2005;365(9466):1231–1238
   PubMed Web of Science ®Google Scholar
• Devarajan P. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr. 2011;23(2):194–200
   PubMed Web of Science ®Google Scholar
• Ichimura T, Mou S. Kidney injury molecule-1 in acute kidney injury and renal repair: A review. Zhong Xi Yi Jie He Xue Bao. 2008;6(5):533–538
   PubMedGoogle Scholar
• Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W. Urinary and serum biomarkers for the diagnosis of acute kidney injury: An in-depth review of the literature. Nephrol Dial Transplant. 2013;28(2):254–273
   PubMed Web of Science ®Google Scholar
• Mishra J, Mori K, Ma Q, et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 2004;15(12):3073–3082
   PubMed Web of Science ®Google Scholar
• Ye RG, Xu HS. The diagnosis value of urinary lysozyme and N-acetyl beta glucosaminidase in renal tubulointerstitial diseases. Chin J Pract Intern Med. 1999;19:198–199
   Google Scholar
• Nakamura T, Sugaya T, Node K, Ueda Y, Koide H. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis. 2006;47(3):439–444
   PubMed Web of Science ®Google Scholar
• Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1: A tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol. 2004;286(3):F552–F563
   PubMed Web of Science ®Google Scholar
• Traxer O, Smith TG III, Pearle MS, Corwin TS, Saboorian H, Cadeddu JA. Renal parenchymal injury after standard and mini percutaneous nephrostolithotomy. J Urol. 2001;165(5):1693–1695
   PubMed Web of Science ®Google Scholar
• Moskovitz B, Halachmi S, Sopov V, et al. Effect of percutaneous nephrolithotripsy on renal function: Assessment with quantitative SPECT of (99m)Tc-DMSA renal scintigraphy. J Endourol. 2006;20(2):102–106
   PubMed Web of Science ®Google Scholar
• Ting YT, Coates PT, Walker RJ, McLellan AD. Urinary tubular biomarkers as potential early predictors of renal allograft rejection. Nephrology (Carlton). 2012;17(1):11–16
   PubMed Web of Science ®Google Scholar
• Zhou Y, Vaidya VS, Brown RP, et al. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci. 2008;101(1):159–170
   PubMed Web of Science ®Google Scholar
• Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM1): A novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62(1):237–244
   PubMed Web of Science ®Google Scholar
• Waanders F, van Timmeren MM, Stegeman CA, Bakker SJ, van Goor H. Kidney injury molecule-1 in renal disease. J Pathol. 2010;220(1):7–16
   PubMed Web of Science ®Google Scholar
• Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273(7):4135–4142
   PubMed Web of Science ®Google Scholar
• Bonventre JV. Kidney Injury Molecule-1 (KIM-1): A specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest Suppl. 2008;241:78–83
   PubMedGoogle Scholar
• Huang Y, Don-Wauchope AC. The clinical utility of kidney injury molecule 1 in the prediction, diagnosis and prognosis of acute kidney injury: A systematic review. Inflamm Allergy Drug Targets. 2011;10(4):260–271
   PubMedGoogle Scholar
• Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review. Kidney Int. 2008;73(9):1008–1016
   PubMed Web of Science ®Google Scholar
• Chaturvedi S, Farmer T, Kapke GF. Assay validation for KIM-1: Human urinary renal dysfunction biomarker. Int J Biol Sci. 2009;5:128–134
   PubMed Web of Science ®Google Scholar
• Bonventre JV. Kidney injury molecule-1 (KIM-1): A urinary biomarker and much more. Nephrol Dial Transplant. 2009;24:3265–3268
   PubMed Web of Science ®Google Scholar
• van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007;212:209–217
   PubMed Web of Science ®Google Scholar
• Han WK, Wagener G, Zhu Y, Wang S, Lee HT. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol. 2009;4:873–882
   PubMed Web of Science ®Google Scholar
• Wasilewska A, Taranta-Janusz K, Debek W, Zoch-Zwierz W, Kuroczycka-Saniutycz E. Kim-1 and NGAL: New markers of obstructive nephropaty. Pediatr Nephrol. 2011;26:579–586
   PubMed Web of Science ®Google Scholar
• Dieterle F, Sistare F, Goodsaid F, et al. Renal biomarker qualification submission: A dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat Biotechnol. 2010;28(5):455–462
   PubMed Web of Science ®Google Scholar
• Singer E, Markó L, Paragas N, et al. Neutrophil gelatinase-associated lipocalin: Pathophysiology and clinical applications. Acta Physiol (Oxf). 2013;207(4):663–672
   PubMed Web of Science ®Google Scholar
• Xu S, Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta. 2000;1482(1-2):298–307
   PubMed Web of Science ®Google Scholar
• Thomas AA, Demirjian S, Lane BR, et al. Acute kidney injury: Novel biomarkers and potential utility for patient care in urology. Urology. 2011;77(1):5–11
   PubMed Web of Science ®Google Scholar
• Devarajan P, Mishra J, Supavekin S, Patterson LT, Steven Potter S. Gene expression in early ischemic renal injury: Clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab. 2003;80(4):365–376
   PubMed Web of Science ®Google Scholar
• Negishi K, Noiri E, Doi K, et al. Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury. Am J Pathol. 2009;174(4):1154–1159
   PubMed Web of Science ®Google Scholar
• Portilla D, Dent C, Sugaya T, et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2008;73(4):465–472
   PubMed Web of Science ®Google Scholar
• D’Amico G, Bazzi C. Urinary protein and enzyme excretion as markers of tubular damage. Curr Opin Nephrol Hypertens. 2003;12(6):639–643
   PubMed Web of Science ®Google Scholar